A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, UK, on March 8, 2024. Hollie Adams/ReutersGlobal pharmaceutical firm Novo Nordisk on Feb. 24 announced that as of Jan. 1, 2027, it will lower the list price, or wholesale acquisition cost, for its popular weight-loss drugs Ozempic and Wegovy by up to 50 percent.This will include Wegovy (semaglutide) 2.4 injections and 25 mg tablets, Ozempic (semaglutide) 0.5 mg, 1 mg, and 2 mg injections, and Rybelsus (semaglutide) 7 mg or 14 mg tablets to $675—equating to a reduction of nearly 50 percent for Wegovy and 35 percent of Ozempic from the current list prices.
Novo Nordisk to Cut Ozempic, Wegovy Prices Up to 50 Percent in US
Date:
